ArticleCureus2026
Autoimmune Encephalitis Masquerading As Acute Psychosis: A Cause of Delayed Treatment.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune encephalitis (AE) can masquerade as severe psychosis and is often misdiagnosed as a primary psychiatric disorder, leading to delays in treatment. In cases of acute onset of psychiatric symptoms, it is important to rule out encephalitis, especially when symptoms are accompanied by neurological signs such as seizures. We report the case of a 22-year-old male who was initially diagnosed with acute psychosis and admitted to an inpatient psychiatry ward. The presence of recurrent seizures raised concern for AE, prompting transfer to the medical intensive care unit. Following a comprehensive workup, he was diagnosed with anti-N-methyl-D-aspartate (NMDA) receptor AE and treated with immunomodulatory therapy, resulting in the resolution of symptoms. This case highlights the importance of increased clinician awareness for early diagnosis and timely initiation of treatment to improve patient outcomes. We also discuss various diagnostic criteria and scoring systems that may assist clinicians in guiding testing and management of AE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.